allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq 1 UNT Injection [Tregzi]
RxNorm concept 2747379, branded drug (sbd). Prescribable name: TREGZI Cell Suspension for Infusion.
- RxCUI
- 2747379
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2747379 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Tregzi Cell Suspension for Infusion
Related concepts
- allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq 1 UNT (SCDC, consists of)
- allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq 1 UNT [Tregzi] (SBDC, consists of)
- Injection (DF, has dose form)
- Tregzi (BN, has ingredient)
- allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq 1 UNT Injection (SCD, tradename of)
Linked data
NDCs
- 85866012302
- 85866012401
- 85866012501
- 85866012601
- 85866012602
- 85866022304
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2747379 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2747379 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2747379. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.